European Archives - Page 166 of 1392 - European Medical Journal

Lilly's TuneLab to share AI models with small biotechs

Lilly has launched TuneLab, giving biotech companies access to AI-powered drug discovery models based on over £1bn in research investment.

Corrigendum: Diabetic Ketoacidosis in Pregnancy: An Overview of Pathophysiology, Management, and Pregnancy Outcomes

Central Lung Tumour Location Tied to Worse Outcomes Post-Surgery

Central tumour location linked to worse survival in lung cancer, suggesting need for closer post-operation monitoring.

Sara Tolaney

Onc Now: Episode 25: From Trials to Treatment in Breast Cancer Care

Sara Tolaney shares insights on breast cancer care, including her research on CDK4/6 inhibitors and exploring ways to de-escalate treatment.

Prognostic Power of Detecting Minimal Residual Disease in Ovarian Cancer

Minimal residual disease (MRD) is a major barrier to curing advanced ovarian cancer, even in patients who appear disease-free after initial therapy. A recent study of 95 patients showed that MRD detected through second-look laparoscopy or circulating tumor DNA strongly predicted shorter progression-free and overall survival.

Single Hair Strand Can Identify Amyotrophic Lateral Sclerosis Biomarkers

See how new hair analysis could help detect ALS earlier and simplify diagnosis. Find out more by continuing to read.

Erratum: Patient-Reported Outcome Measures, 1 Year After COVID-19

High-Intensity Exercise Shows Promise in Treating Depression

Discover how high-intensity exercise offers small but meaningful improvements in depression, especially for older individuals.

Paternal HBV Status Not a Barrier to ART Success

Understand how paternal hepatitis B has no significant effect on ART pregnancy or live birth outcomes.

Is H. Pylori Screening After Heart Attack Necessary?

Learn if post-heart attack H. pylori screening prevents gastrointestinal bleeding and who might benefit. Keep reading for insights.